SANTA MARIA PETROLEUM INC

Inactive Instrument

Insiders Santa Maria Petroleum Inc Toronto S.E.

Equities

SMQ

CA80234R1001

End-of-day quote Toronto S.E. Other stock markets
- ^CAD	-

2021	Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107	MT
2021	Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kalytera Therapeutics, Inc. will Change its Name to Claritas Pharmaceuticals, Inc	21-04-12	CI
Claritas Pharmaceuticals, Inc. Appoints Perenlei Enkhbaatar as an Independent Member of the Company’s Board of Directors, Effective Immediately	21-03-26	CI
Claritas Pharmaceuticals, Inc. Announces Board Changes	21-03-18	CI
Claritas (Formerly Kalytera Therapeutics, Inc.) Announces Addition of Professor Salvatore Cuzzocrea to the Board of Directors	21-03-05	CI
Kalytera Announces Changes to Board of Directors	19-06-21	CI
Kalytera Announces Formation of Strategic and Scientific Advisory Board	18-05-15	CI
Kalytera Therapeutics, Inc. Appoints Gary Leong as Member of the Audit Committee	17-05-31	CI
Kalytera Therapeutics, Inc. Announces Executive Changes	17-05-26	CI
Kalytera Therapeutics, Inc. Appoints Pini Ben-Elazar to Board of Directors	17-03-17	CI
Kalytera Therapeutics, Inc. Appoints Dr. Andrew Salzman as Chief Medical Officer	16-08-23	CI
Kalytera Therapeutics Appoints Dr. Stuart Silverman as Senior Vice President of Medical Affairs	16-06-27	CI
Kalytera Therapeutics, Inc. Appoints Robert S. Langer to the Scientific Advisory Board	16-06-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer